Astrana Health director exercises 20,000 stock options

Astrana Health, Inc. director John Chiang exercised fully vested stock options for 20,000 shares of common stock on August 13, 2025 at an exercise price of $18.20 per share.

Rhea-AI Filing Summary

Astrana Health, Inc. director John Chiang exercised fully vested stock options for 20,000 shares of common stock on August 13, 2025 at an exercise price of $18.20 per share. To satisfy tax obligations, 12,284 shares were withheld at $29.63 per share. Following these transactions, Chiang directly holds 30,848 Astrana Health common shares, including 6,449 restricted shares scheduled to vest on the earlier of June 11, 2026 or the company’s 2026 annual meeting of stockholders.

Insights

Securities Analyst

TL;DR: Director exercised vested options for 20,000 shares and sold 12,284 shares, modestly increasing directly held equity while realizing proceeds.

The director's exercise of options at $18.20 resulted in 20,000 newly acquired common shares, a straightforward cashless or paid exercise consistent with monetizing vested compensation. The contemporaneous sale of 12,284 shares at $29.63 suggests partial liquidation of holdings post-exercise or routine portfolio rebalancing. The filing discloses 6,449 restricted shares that remain subject to future vesting conditions, which limits immediate liquidity for that portion. Overall, the transactions are material to insider ownership tracking but do not alone indicate a change in control or significant dilution.

Corporate Governance Expert

TL;DR: Transactions reflect routine director compensation exercise and a taxable disposition; no governance red flags disclosed.

The report confirms the options were fully vested and exercisable at the time of exercise, meeting typical grant vesting conditions. The presence of restricted stock that vests by a specified corporate event is standard and aligns the director's incentives with shareholder meetings. There are no disclosures here of pledging, transfers to affiliates, or unusual derivative structures. From a governance perspective, these are normal insider activities but should be monitored alongside future filings for any pattern of consistent large-scale sales.

Insider Trade Summary

20,000 shares exercised/converted

Exercise 3 txns

Insider Chiang John

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	20,000	$0.00	$0.00
Exercise	Common Stock	20,000	$18.20	$364K
Exercise Price or Tax Liability	Common Stock	12,284	$29.63	$364K

Holdings After Transaction: Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 30,848 shares (Direct)

Footnotes (2)

1. F1. These stock options were fully vested and exercisable.
2. F2. Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

Key Figures

Options Exercised: 20,000 shares Exercise Price: $18.20 per share Shares Withheld for Taxes: 12,284 shares +3 more

6 metrics

Options Exercised 20,000 shares Stock options exercised on August 13, 2025 into common stock

Exercise Price $18.20 per share Conversion or exercise price of the stock options

Shares Withheld for Taxes 12,284 shares Common shares delivered to cover tax obligations on the exercise

Tax Withholding Price $29.63 per share Per-share value used for the tax-withholding disposition

Post-Transaction Holdings 30,848 shares Direct Astrana Health common stock position after the transactions

Restricted Shares 6,449 shares Restricted stock vesting by June 11, 2026 or the 2026 annual meeting

Key Terms

Stock Option (right to buy), tax-withholding disposition, restricted stock

3 terms

Stock Option (right to buy) financial

"security_title "Stock Option (right to buy)" for the derivative transaction"

tax-withholding disposition financial

"transaction_action "tax-withholding disposition" describing the F-code transaction"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

restricted stock financial

"Includes 6,449 shares of restricted stock, which will vest..."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Astrana Health (ASTH) director John Chiang report?

John Chiang exercised 20,000 stock options for Astrana Health common shares at $18.20 per share and had 12,284 shares withheld at $29.63 per share for taxes, leaving him with 30,848 common shares held directly.

How many Astrana Health (ASTH) shares did John Chiang acquire through option exercise?

John Chiang acquired 20,000 shares of Astrana Health common stock by exercising fully vested stock options at an exercise price of $18.20 per share on August 13, 2025, converting his derivative position into additional directly held common shares.

What tax-withholding disposition was reported for Astrana Health (ASTH)?

The Form 4 reports a tax-withholding disposition of 12,284 common shares of Astrana Health delivered at $29.63 per share to satisfy tax obligations associated with the option exercise, reducing the net number of shares retained from the exercised options.

How many Astrana Health (ASTH) shares does John Chiang hold after these transactions?

After the reported transactions, John Chiang holds 30,848 Astrana Health common shares directly. This total includes both unrestricted and 6,449 restricted shares, as disclosed in the accompanying footnote describing his post-transaction ownership structure.

When will John Chiang’s restricted Astrana Health (ASTH) shares vest?

Chiang’s 6,449 restricted shares of Astrana Health common stock will vest on the earlier of June 11, 2026 or the company’s 2026 annual meeting of stockholders, according to the footnote describing the vesting schedule for his restricted stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2025 - 08:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chiang John

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVE, 2ND FLOOR

(Street)

ALHAMBRA CA 91801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		M		20,000	A	$18.2	43,132	D
Common Stock	08/13/2025		F		12,284	D	$29.63	30,848(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$18.2	08/13/2025		M			20,000	(1)	11/11/2025	Common Stock	20,000	$0	0	D

Explanation of Responses:

1. These stock options were fully vested and exercisable.

2. Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

	/s/ Kathy Diep, as Attorney-in-Fact	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.